PSNL vs SRPT · rev $37.8M vs rev $1.13B
Personalis Inc (PSNL) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Personalis Inc (PSNL) is a diagnostics & research company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported PSNL revenue for 2026-06-30 was $37.8M. Net income was -$61.7M. PSNL currently screens at market cap $1.02B.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
PSNL currently screens at market cap $1.02B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the PSNL and SRPT stock pages for the full models.
Not investment advice.